Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

Sunshine Biopharma (SBFM) Accumulated Depreciation & Amortization: 2016-2025

Historic Accumulated Depreciation & Amortization for Sunshine Biopharma (SBFM) over the last 1 years, with Sep 2025 value amounting to $462,469.

  • Sunshine Biopharma's Accumulated Depreciation & Amortization was N/A to $462,469 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year change of. This contributed to the annual value of $336,533 for FY2024, which is 77.13% up from last year.
  • Sunshine Biopharma's Accumulated Depreciation & Amortization amounted to $462,469 in Q3 2025, which was up 12.08% from $412,626 recorded in Q2 2025.
  • Sunshine Biopharma's Accumulated Depreciation & Amortization's 5-year high stood at $462,469 during Q3 2025, with a 5-year trough of $83,806 in Q4 2022.
  • Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $369,180 (2025), whereas its average is $354,161.
  • Data for Sunshine Biopharma's Accumulated Depreciation & Amortization shows a peak YoY spiked of 126.71% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Sunshine Biopharma's Accumulated Depreciation & Amortization stood at $83,806 in 2022, then surged by 126.71% to $189,996 in 2023, then soared by 77.13% to $336,533 in 2024, then reached $462,469 in 2025.
  • Its Accumulated Depreciation & Amortization stands at $462,469 for Q3 2025, versus $412,626 for Q2 2025 and $369,180 for Q1 2025.